Clinical Trials Directory

Trials / Unknown

UnknownNCT02785809

Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception

Recovery of Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception: Is the Recovery Period Related to AMH?

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Anders Nyboe Andersen · Academic / Other
Sex
Female
Age
26 Years – 40 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate whether there is a correlation between anti-Müllerian hormone during long-term use of combined oral contraceptives and the recovery time before recovered menstrual cycle after discontinuation of oral contraceptives.

Detailed description

Background: Hormonal contraception is widely used among women worldwide; 50-89% of all women in the Western countries use oral contraception at some point in their lives. Oral contraceptives (OC) suppress the hypothalamic-pituitary-ovarian axis through a negative feedback of ethinyl estradiol and progestins and thereby potentially influence the markers of ovarian reserve due to a suppressed release of gonadotropins, which will impair the growth of antral follicles. Methods and Materials: Participants for this studies will be included through the Fertility Assessment and Counseling Clinic, Rigshospitalet, Herlev- and Hvidovre Hospital. Inclusion criteria: Use of oral contraception (for study 3 at least during the last three years). Exclusion criteria: Known infertility, known thyroid disease. Aims: Study 3: Investigate the ovarian reserve markers after discontinuation of OC over a period of three months in women with a history of long-term OC use. The women will be followed with serial ultrasounds and blood samples and will complete a menstrual calendar.

Conditions

Interventions

TypeNameDescription
OTHERPausing oral contraceptive

Timeline

Start date
2016-04-01
Primary completion
2019-05-01
Completion
2020-03-01
First posted
2016-05-30
Last updated
2016-05-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02785809. Inclusion in this directory is not an endorsement.